Ribocil

Last updated
Ribocil
Ribocil.png
Names
IUPAC name
2-[1-[[2-(methylamino)pyrimidin-5-yl]methyl]piperidin-3-yl]-4-thiophen-2-yl-1H-pyrimidin-6-one
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
PubChem CID
  • InChI=1S/C19H22N6OS/c1-20-19-21-9-13(10-22-19)11-25-6-2-4-14(12-25)18-23-15(8-17(26)24-18)16-5-3-7-27-16/h3,5,7-10,14H,2,4,6,11-12H2,1H3,(H,20,21,22)(H,23,24,26)
    Key: ZSXCVAIJFUEGJR-UHFFFAOYSA-N
  • CNC1=NC=C(C=N1)CN2CCCC(C2)C3=NC(=CC(=O)N3)C4=CC=CS4
Properties
C19H22N6OS
Molar mass 382.5 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Ribocil is chemical compound which is found to be a potent inhibitor of the FMN riboswitch, meaning it could serve as a promising lead compound for developing a new antibiotic class. The compound was discovered by Merck & Co. through a phenotypic screen of the Gram-positive bacteria Staphylococcus aureus. [1] The binding mode of this small molecule to its binding site has been confirmed through the use of X-Ray crystallography. [2]

Contents

Binding mode

X-Ray crystallography of the FMN riboswitch bound to FMN (upper, PDB code: 2yie) and ribocil (lower, PDB code: 5c45) and juxtaposed (middle). Residues which form interactions with the binders are highlighted with text. Binding mode.png
X-Ray crystallography of the FMN riboswitch bound to FMN (upper, PDB code: 2yie) and ribocil (lower, PDB code: 5c45) and juxtaposed (middle). Residues which form interactions with the binders are highlighted with text.

The structure of ribocil versus previously discovered binders to the FMN riboswitch makes it unique, as it is not a structural analogue to the natural ligand, flavin mononucleotide (FMN). The binding mode of this compound has some similarities with ribocil, where the same π-π stacking interaction and two hydrogen bond is also conserved. Ribocil also makes two new contacts with the binding site which notably differs from FMN: a π-π interaction between the aminopyrimidine of ribocil and residue G62 and an edge-face π-interaction. [2]

Challenges and derivatives

One major obstacle of using ribocil as a bona fide antibiotic is that although it kills bacteria in culture, Gram-positive organisms can scavenge riboflavin from their environment. [3] While ribocil in itself has no activity towards Gram-negative bacteria, derivatives of ribocil which enhance the accumulative properties of these compounds have been synthesized to show whole-cell activity against wild-type strains of these bacteria. [1] [3] [4]

References

  1. 1 2 Howe, John A.; Wang, Hao; Fischmann, Thierry O.; Balibar, Carl J.; Xiao, Li; Galgoci, Andrew M.; Malinverni, Juliana C.; Mayhood, Todd; Villafania, Artjohn; Nahvi, Ali; Murgolo, Nicholas; Barbieri, Christopher M.; Mann, Paul A.; Carr, Donna; Xia, Ellen; Zuck, Paul; Riley, Dan; Painter, Ronald E.; Walker, Scott S.; Sherborne, Brad; de Jesus, Reynalda; Pan, Weidong; Plotkin, Michael A.; Wu, Jin; Rindgen, Diane; Cummings, John; Garlisi, Charles G.; Zhang, Rumin; Sheth, Payal R.; Gill, Charles J.; Tang, Haifeng; Roemer, Terry (2015-10-29). "Selective small-molecule inhibition of an RNA structural element". Nature. 526 (7575): 672–677. Bibcode:2015Natur.526..672H. doi:10.1038/nature15542. ISSN   0028-0836. PMID   26416753 . Retrieved 2017-02-02.
  2. 1 2 Howe, John A.; Xiao, Li; Fischmann, Thierry O.; Wang, Hao; Tang, Haifeng; Villafania, Artjohn; Zhang, Rumin; Barbieri, Christopher M.; Roemer, Terry (2016-10-02). "Atomic resolution mechanistic studies of ribocil: A highly selective unnatural ligand mimic of the E. coli FMN riboswitch". RNA Biology. 13 (10): 946–954. doi:10.1080/15476286.2016.1216304. ISSN   1547-6286. PMC   5056776 . PMID   27485612 . Retrieved 2020-09-08.
  3. 1 2 Wang, Hao; Mann, Paul A.; Xiao, Li; Gill, Charles; Galgoci, Andrew M.; Howe, John A.; Villafania, Artjohn; Barbieri, Christopher M.; Malinverni, Juliana C.; Sher, Xinwei; Mayhood, Todd; McCurry, Megan D.; Murgolo, Nicholas; Flattery, Amy; Mack, Matthias (2017-05-18). "Dual-Targeting Small-Molecule Inhibitors of the Staphylococcus aureus FMN Riboswitch Disrupt Riboflavin Homeostasis in an Infectious Setting". Cell Chemical Biology. 24 (5): 576–588.e6. doi:10.1016/j.chembiol.2017.03.014. ISSN   2451-9456. PMID   28434876.
  4. ↑ Motika, Stephen E.; Ulrich, Rebecca J.; Geddes, Emily J.; Lee, Hyang Yeon; Lau, Gee W.; Hergenrother, Paul J. (2020-06-17). "Gram-Negative Antibiotic Active Through Inhibition of an Essential Riboswitch". Journal of the American Chemical Society. 142 (24): 10856–10862. Bibcode:2020JAChS.14210856M. doi:10.1021/jacs.0c04427. ISSN   0002-7863. PMC   7405991 . PMID   32432858.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.